The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Interventions for valvular disease and heart failure
Quantitative aortography assessment of aortic regurgitation
Rodrigo Modolo1,2, MD; Chun Chin Chang3, MD; Yoshinobu Onuma4, MD, PhD; Carl Schultz3, MD, PhD; Hiroki Tateishi5, MD, PhD; Mohammad Abdelghani1,6, MD; Yosuke Miyazaki5,3, MD, PhD; Jean-Paul Aben7, MSc; Marcel C.M. Rutten8, PhD; Michele Pighi9, MD; Abdelhak El Bouziani1, MD; Martijn van Mourik1, PhD; Pedro A. Lemos10,11, MD, PhD; Joanna J. Wykrzykowska1, MD, PhD; Fabio Sandoli Brito Jr10, MD, PhD; Cherif Sahyoun12, PhD; Nicolo Piazza9, MD, PhD; Hélène Eltchaninoff13, MD, PhD; Osama Soliman4, MD, PhD; Mohamed Abdel-Wahab6,14, MD, PhD; Nicolas M. Van Mieghem3, MD, PhD; Robbert J. de Winter1, MD, PhD; Patrick W. Serruys4, MD, PhD
1. Department of Cardiology, Amsterdam UMC, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, the Netherlands; 2. Department of Internal Medicine, Cardiology Division. University of Campinas (UNICAMP), Campinas, Brazil; 3. Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands; 4. Department of Cardiology, National University of Ireland, Galway, Ireland; 5. Division of Cardiology, Department of Clinical Science and Medicine- Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan; 6. The Heart Center, Segeberger Kliniken, Bad Segeberg, Germany; 7. Pie Medical Imaging, Maastricht, the Netherlands; 8. Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands; 9. Division of Cardiology, McGill University Health Centre, Montreal, QC, Canada; 10. The Heart Institute (InCor), University of Sao Paulo Medical School, Sao Paulo, Brazil; 11. Hospital Israelita Albert Einstein, Sao Paulo, Brazil; 12. Philips Healthcare, Best, the Netherlands; 13. Cardiology Service, Rouen-Charles-Nicolle University Hospital Center, National Institute of Health and Medical Research U644, Rouen, France; 14. Cardiology Department, Heart Center Leipzig at the University of Leipzig, Leipzig, Germany
Introduction
Transcatheter aortic valve implantation (TAVI) is undeniably invading the “surgical” space and expanding its indication. Over the last five years, there has been a real revolution in TAVI technology with the introduction of newer devices that aimed to simplify the procedure1. These swift advances have transformed the landscape in structural heart disease and culminated in a broader use of TAVI in clinical practice2,3. The procedure is not only spreading worldwide but is also becoming less aggressive for the patient with the so-called “minimalist approach”.
With the rise and consolidation of this minimally ...
Sign in to read and download the full article
Forgot your password? No account yet?
Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
Interventions for valvular diseaseTAVI
Read next article
Risk of coronary obstruction and the need to perform BASILICA: the VIVID classification
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023